Purified human chorionic gonadotropin induces apoptosis in breast cancer

Molecular Cancer Therapeutics

Volumn 7, Issue 9, 2008, Pages 2837-2844

  Lopez, Dayami ^a   Sekharam, Madhavi ^a   Coppola, Domenico ^a   Carter, W Bradford ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ASPARTATE AMMONIA LIGASE; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INHIBIN; INTERLEUKIN 1BETA; LUTEINIZING HORMONE RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN BCL X; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICE; MICE, NUDE; NEOPLASM PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 54049107383     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-0339     Document Type: Article

References (38)

1. Lapthorn AJ, Harris DC, Littlejohn A, et al. Crystal structure of human chorionic gonadotropin. Nature 1994;369:455-61.
2. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem 1981;50:465-95.
3. Russo J, Russo IH. The etiopathogenesis of breast cancer prevention. Cancer Lett 1995;90:81-9.
4. Srivastava P, Russo J, Russo IH. Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin. Mol Carcinog 1999;26:10-9.
5. Loosfelt H, Misrahi M, Atger M, et al. Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain. Science 1989;245:525-8.
6. McFarland KC, Sprengel R, Phillips HS, et al. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 1989;245:494-9.
7. Hu YL, Lei ZM, Huang ZH, Rao CV. Determinants of transcription of the chorionic gonadotropin/luteinizing hormone receptor gene in human breast cells. Breast J 1999;5:186-93.
8. Lojun S, Bao S, Lei ZM, Rao CV. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer. Biol Reprod 1997;57:1202-10.
9. Meduri G, Charnaux N, Loosfelt H, et al. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 1997;57:857-64.
10. Meduri G, Charnaux N, Spyratos F, Hacene K, Loosfelt H, Milgrom E. Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomas. Cancer 2003;97:1810-6.
11. Span PN, Manders P, Heuvel JJ, et al. Molecular beacon reverse transcription-PCR of human chorionic gonadotropin-β-3, -5, and -8 mRNAs has prognostic value in breast cancer. Clin Chem 2003;49:1074-80.
12. Taback B, Chan AD, Kuo CT, et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 2001;61:8845-50.
13. Janssens JP, Russo J, Russo IH, et al. Human chorionic gonadotropin (hCG) and prevention of breast cancer. Mol Cell Endocrinol 2007;269:93-8.
14. Rao CV. Does full-term pregnancy at a young age protect women against breast cancer through hCG? Obstet Gynecol 2000;96:783-6.
15. Russo IH, Russo J. Hormonal approach to breast cancer prevention. J Cell Biochem 2000;Suppl 34:1-6.
16. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
17. Lambe M, Hsieh C, Tsaih S, Ekbom A, Adami HO, Trichopoulos D. Maternal risk of breast cancer following multiple births: a nationwide study in Sweden. Cancer Causes Control 1996;7:533-8.
18. MacMahon B, Cole P, Lin TM, et al. Age at first birth and breast cancer risk. Bull World Health Organ 1970;43:209-21.
19. Medina D. Breast cancer: the protective effect of pregnancy. Clin Cancer Res 2004;10:380-4S.
20. Trapido EJ. Age at first birth, parity, and breast cancer risk. Cancer 1983;51:946-8.
21. Srivastava P, Russo J, Russo IH. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis 1997;18:1799-808.
22. Alvarado MV, Alvarado NE, Russo J, Russo IH. Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. In Vitro Cell Dev Biol Anim 1994;30A:4-8.
23. Guo S, Russo IH, Lareef MH, Russo J. Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol 2004;24:399-407.
24. Srivastava P, Russo J, Mgbonyebi OP, Russo IH. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Anticancer Res 1998;18:4003-10.
25. Rao CV, Li X, Manna SK, Lei ZM, Aggarwal BB. Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-κB and AP-1 activation. J Biol Chem 2004;279:25503-10.
26. Bièche I, Lazar V, Noguès C, et al. Prognostic value of chorionic gonadotropin β gene transcripts in human breast carcinoma. Clin Cancer Res 1998;4:671-6.
27. Reimer T, Koczan D, Müller H, et al. Human chorionic gonadotrophin-β transcripts correlate with progesterone receptor values in breast carcinomas. J Mol Endocrinol 2000;24:33-41.
28. Cho-Chung YS, Clair T, Bodwin JS, Berghoffer B. Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science 1981;214:77-9.
29. Chen J, Bander JA, Santore TA, et al. Expression of Q227L-galphas in MCF-7 human breast cancer cells inhibits tumorigenesis. Proc Natl Acad Sci U S A 1998;95:2648-52.
30. Gill PS, Lunardi-Ishkandar Y, Louie S, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med 1996;335:1261-9.
31. Kachra Z, Guo WX, Sairam MR, Antakly T. Low molecular weight components but not dimeric HCG inhibit growth and down-regulate AP-1 transcription factor in Kaposi's sarcoma cells. Endocrinology 1997;138:4038-41.
32. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995;375:64-8.
33. Pati S, Lee Y, Samaniego F. Urinary proteins with pro-apoptotic and antitumor activity. Apoptosis 2000;5:21-8.
34. Samaniego F, Bryant JL, Liu N, et al. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin. J Natl Cancer Inst 1999;91:135-43.
35. Masood R, McGarvey ME, Zheng T, et al. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo. Blood 1999;93:1038-44.
36. Butler SA, Iles RK. Ectopic human chorionic gonadotropin β secretion by epithelial tumors and human chorionic gonadotropin β-induced apoptosis in Kaposi's sarcoma: is there a connection?. Clin Cancer Res 2003;9:4666-73.
37. Malatos S, Neubert H, Kicman AT, Iles RK. Identification of placental transformingg rowth factor-β and bikunin metabolites as contaminants of pharmaceutical human chorionic gonadotrophin preparations by proteomic techniques. Mol Cell Proteomics 2005;4:984-92.
38. Lang ME, Lottersberger C, Roth B, et al. Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin. AIDS 1997;11:1333-40.